Cat. No.: DIA-0243321
Product Information | |
---|---|
CAS No. | 100750-39-8 |
Formula | C14H13NO3 |
Molecular Weight | 243.26 |
SMILES | CC(N1C(C2=CC=CC=C2)=CC(OC(C)=O)=C1)=O |
Target | Aldose Reductase, Apoptosis |
Product Description | APPA is an aldose reductase inhibitor. APPA can effectively prevent apoptosis and the symptoms of Streptozotocin (HY-13753)-induced diabetes by inhibiting the polyol pathway in rats. APPA has the potential for diabetic nephropathy (DN) research. |
Format & Storage | |
---|---|
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.